Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
LOW RISK
Score updated Aug 28, 2026

SLS — SELLAS Life Sciences Group, Inc. Dilution Risk Tracker

Track SLS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLS — Get alerts when the score changes →

As of August 28, 2026, SELLAS Life Sciences Group, Inc. (SLS) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. SELLAS Life Sciences Group, Inc. has a market capitalization of $1.73B, 201.95M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include 818.9K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SLS.
🔔 Track SLS — Get forecast alerts →

Market Data

Market Cap$1.73B
Shares Outstanding201.95M
Float185.23M
Cash$138.34M
Debt$871.0K
Short InterestN/A

Institutional Holdings

10 institutional holders · 41.02M shares
#1 Blackrock Inc. 12.20M shares
#2 State Street Corporation 8.40M shares
#3 Vanguard Capital Management LLC 7.53M shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest54.98M
Days to Cover7.9
% of Float29.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2017-12-31
4 INSIDER TRANSACTION 2026-06-18
8-K 8K EVENT 2026-06-02
8-K 8K EVENT 2026-03-11
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SLS Dilution Snapshot

SELLAS Life Sciences Group, Inc. (SLS) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SLS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SLS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SLS
SLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.